Approval · Notice of Compliance 25680 · 2021
EVRYSDI: Notice of Compliance 25680
Issued April 14, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25680
- Date
- April 14, 2021
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EVRYSDI | 02514931 | Marketed |
Medicinal ingredients
- RISDIPLAM 0.75 MG per ML